![](/img/cover-not-exists.png)
Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)
Schmoll, H.-J., Cunningham, D., Sobrero, A., Karapetis, C. S., Rougier, P., Koski, S. L., Kocakova, I., Bondarenko, I., Bodoky, G., Mainwaring, P., Salazar, R., Barker, P., Mookerjee, B., Robertson, JVolume:
30
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2012.42.5355
Date:
October, 2012
File:
PDF, 205 KB
english, 2012